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BackgroundzzFacial diplegia has diverse etiologies, including viral and bacterial infections such 
as diphtheria, syphilis and Lyme disease, and also protozoal infection in very rarely cases.
Case ReportzzA 20-year-old male patient was admitted to our hospital due to bilateral weak-
ness of the upper and lower facial muscles. Examination revealed that the patient had a facial di-
plegia of the peripheral type. A peripheral blood smear demonstrated the presence of the asexual 
trophozoite stage of Plasmodium vivax with ring-form trophozoites, which led to a diagnosis of 
malaria. A serum work-up revealed increased IgG titers of antibodies to myelin-associated gly-
coprotein and ganglioside GD1b. The patient was administered antimalarial treatment, 1 week 
after which he showed signs of recovery. To our knowledge, this is the first case of facial diplegia 
after malaria infection, providing evidence that the mechanism underlying the condition is related 
to immune-mediated disease.
ConclusionszzFacial diplegia can manifest after P. vivax infection.
 J Clin Neurol 2010;6:102-103
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Introduction
Facial diplegia can be induced by inflammatory, infective, trau-
matic, and infiltrative causes. Keane found that benign and 
self-limited syndromes were responsible for one-half of cases.1 
One of the most common underlying causes is Guillain-Barré 
syndrome (GBS), which itself is attributable to nondescript 
respiratory or gastrointestinal infections, especially from virus-
es. Serologic reports have found other types of bacterial infec-
tions, including mycoplasma pneumonia, Lyme disease, and 
Campylobacter jejuni.2 Protozoal infection has also been sug-
gested as a cause of GBS, but the incidence is reportedly very 
rare. We report herein facial diplegia in a male patient with 
malaria.
Case Report
A 20-year-old male patient was admitted to our hospital in 
July 2008, due to bilateral weakness of the upper and lower 
facial muscles associated with facial palsy. He reported a high 
fever and headache that had lasted for 3 weeks. Four days be-
fore admission, he had experienced difficulty closing his eye-
lids and the next day felt facial weakness. On admission, his 
temperature was 38.3℃. Neurological examination revealed 
his pupils to be isocoric with prompt reflexes to both direct 
and indirect light; his extraocular movements were full and 
there was no nystagmus. Bilateral facial weakness of the pe-
ripheral type was noted: the patient was unable to close his 
eyes tightly, smile, blow, or whistle. He did not complain of 
hyperacusis and his gag reflex was normal. Further examina-
tion revealed normal power in all four limbs. The patient’s 
deep tendon reflexes were normal and his sensory functions 
were not impaired.
A peripheral blood smear demonstrated the presence of the 
asexual trophozoite stage of the protozoal parasite Plasmodium 
vivax, with ring-form trophozoites. The patient’s hemoglobin 
was 13.8 g/dL and his white cell count was 3.92×103/μL, com-
prising 59.7% neutrophils. Serum levels of glucose, sodium, 
and potassium were 116 mg/dL, 137 mM, and 4.7 mM/L, re-
spectively. The patient’s cerebrospinal fluid (CSF) was clear 
in appearance, cells were absent, and levels of protein and glu-
cose were 34.7 mg/dL and 66 mg/dL, respectively. Serologic 
tests for leptospiral infection, Lyme disease, herpes simplex, 
varicella zoster, and Epstein-Barr virus were negative in the 
serum and CSF. His IgG index was 0.03 and his erythrocyte 
sedimentation rate was 38 mm/h. High titers of antibodies to 
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myelin-associated glycoprotein (MAG) were found to be 1,200 
BTU (normal value, <1,000 BTU). Titers of ganglioside GM1 
IgG and IgM were not increased, but anti-GD1b IgG titers 
were increased to 1,180 BTU and anti-GD1b IgM titers were 
within the normal range.
Brain MRI with contrast revealed enhancement of the right 
facial nerve. Ultrasound evaluation of the abdomen revealed 
splenomegaly. Nerve conduction studies of the extremities pro-
duced normal results. Sensory evoked potentials and visual 
evoked potentials were normal, and there were no observable 
R1 or R2 responses in the blink reflex test. On facial EMG, 
denervation potentials founded in the bilateral orbicularis oculi, 
orbicularis oris, and frontalis muscles. Normal EMG record-
ings were observed in the bilateral masseter muscles. Antima-
larial therapy with hydroxychloroquine sulfate was commenced, 
and the patient showed signs of recovery after 1 week.
Discussion
Bilateral facial weakness is present in less than 1% of facial 
palsy patients, with facial paralysis resulting from a wide range 
of congenital abnormalities, cranial trauma, and infections. In 
the present case, facial diplegia developed suddenly after fe-
ver. All laboratory data, including serologic tests, were normal 
except for the anti-MAG and anti-GD1b titers in CSF. These 
results suggest that the cause of the facial diplegia is related 
to an immune-mediated condition, such as GBS.
GBS is a form of peripheral neuropathy that is commonly 
triggered by infections and is related to immune-mediated 
mechanisms. A large number of infectious agents that mediate 
GBS have been identified, but protozoal parasitic infection 
has been reported in only a limited number of patients with 
Leishmania donovani, P. falciparum, and P. vivax malaria.3-6 
To our knowledge, only 22 cases of GBS after malarial infec-
tion have been reported, and this is the first case of facial di-
plegia after a malarial infection.
The mechanisms underlying the malaria-induced develop-
ment of GBS are unknown. The malaria parasite may damage 
the peripheral nerves by vascular occlusion, thus causing an-
oxic stagnation in the vasa nervosum, which leads to tempo-
rary demyelination and recovery after disappearance of the 
parasitemia and establishment of normal blood flow in the 
vasa nervosum. Immune-mediated damage is believed to be 
the cause of GBS. In malaria, asexual-stage infections are ac-
companied by the release of cytokines and other immunologi-
cal mediators.7 In our case, immunologic studies revealed that 
anti-MAG and anti-GD1b titers were elevated, possibly indi-
cating that the development of GBS after malaria infection is 
an immune-mediated disease rather than the result of direct 
damage by parasites.8 Drug-induced polyneuropathy is unlike-
ly, since paralysis occurred in our case before commencing 
treatment.
P. falciparum malaria is associated with a poorer outcome 
compared with other types of malarial infection.5,6,9 In other 
reports, almost half of patients developed respiratory and bul-
bar paralysis, which ultimately leads to death. These findings 
are worse than those usually encountered in GBS.1 However, 
several P. vivax malaria patients, including our case, have sur-
vived and did not develop bulbar involvement.10 The relevant 
patient population is too small to allow us to draw a reliable 
conclusion, but we can assume that P. vivax malaria can be 
complicated by GBS, which has a low incidence of bulbar af-
fection and a better clinical outcome than P. falciparum malaria.
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